Ligature Therapeutics
Ligature Therapeutics is a biotech company that develops small molecules for targeted protein degradation to treat intractable diseases.
Ligature Therapeutics is a business in biotechnology, medical, therapeutics based in Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia, founded in 2020.
As a business in biotechnology, medical, therapeutics, Ligature Therapeutics is listed here with the public details available about it.
The business is associated with Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia.
Its current recorded stage is Seed.
Its team size is recorded as c_00001_00010 employees.
It has disclosed roughly $6M in funding.
| Sector | Biotechnology, Medical, Therapeutics |
|---|---|
| Headquarters | Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $6,000,000 |
Website: ligaturetx.com
Sign in to view the contact information we hold for Ligature Therapeutics.
Create a free account
Create a free account